AU2012307461B2 - Endoglycosidase from Streptococcus pyogenes and methods using it - Google Patents

Endoglycosidase from Streptococcus pyogenes and methods using it Download PDF

Info

Publication number
AU2012307461B2
AU2012307461B2 AU2012307461A AU2012307461A AU2012307461B2 AU 2012307461 B2 AU2012307461 B2 AU 2012307461B2 AU 2012307461 A AU2012307461 A AU 2012307461A AU 2012307461 A AU2012307461 A AU 2012307461A AU 2012307461 B2 AU2012307461 B2 AU 2012307461B2
Authority
AU
Australia
Prior art keywords
igg
endos49
polypeptide
sample
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012307461A
Other languages
English (en)
Other versions
AU2012307461A1 (en
Inventor
Maria Allhorn
Mattias Collin
Jonathan Sjogren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genovis AB
Original Assignee
Genovis AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genovis AB filed Critical Genovis AB
Publication of AU2012307461A1 publication Critical patent/AU2012307461A1/en
Application granted granted Critical
Publication of AU2012307461B2 publication Critical patent/AU2012307461B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01096Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2012307461A 2011-09-13 2012-09-12 Endoglycosidase from Streptococcus pyogenes and methods using it Active AU2012307461B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1115841.7 2011-09-13
GB201115841A GB201115841D0 (en) 2011-09-13 2011-09-13 Protein and method
PCT/EP2012/067841 WO2013037824A1 (en) 2011-09-13 2012-09-12 Endoglycosidase from streptococcus pyogenes and methods using it

Publications (2)

Publication Number Publication Date
AU2012307461A1 AU2012307461A1 (en) 2014-03-27
AU2012307461B2 true AU2012307461B2 (en) 2016-08-18

Family

ID=44908522

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012307461A Active AU2012307461B2 (en) 2011-09-13 2012-09-12 Endoglycosidase from Streptococcus pyogenes and methods using it

Country Status (20)

Country Link
US (1) US9493752B2 (enExample)
EP (1) EP2756077B1 (enExample)
JP (1) JP6076349B2 (enExample)
KR (1) KR102001427B1 (enExample)
CN (1) CN103946377B (enExample)
AU (1) AU2012307461B2 (enExample)
BR (1) BR112014005816A2 (enExample)
CA (1) CA2848230C (enExample)
DK (1) DK2756077T3 (enExample)
EA (1) EA028490B8 (enExample)
ES (1) ES2627334T3 (enExample)
GB (2) GB201115841D0 (enExample)
IL (1) IL231410A0 (enExample)
IN (1) IN2014CN02163A (enExample)
MX (1) MX347727B (enExample)
PL (1) PL2756077T3 (enExample)
PT (1) PT2756077T (enExample)
SG (1) SG11201400505YA (enExample)
WO (1) WO2013037824A1 (enExample)
ZA (1) ZA201401840B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307564T3 (es) * 2000-12-21 2008-12-01 Id Biomedical Corporation Antigenos de streptococcus pyrogenes y fragmentos de adn correspondientes.
HUE038285T2 (hu) 2012-10-23 2018-10-29 Synaffix Bv Módosított antitest, antitest-konjugátum és eljárás ezek elõállítására
SI2991683T1 (sl) 2013-05-02 2020-01-31 Glykos Finland Oy Konjugati glikoproteina ali glikana s toksično obremenitvijo
JP2016538878A (ja) 2013-10-14 2016-12-15 シンアフィックス ビー.ブイ. 糖鎖工学的に操作された抗体、抗体コンジュゲート、及びそれらの調製方法
WO2015057064A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
US10072096B2 (en) 2013-10-14 2018-09-11 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
US20160235861A1 (en) 2013-10-14 2016-08-18 SynAffix. B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
GB201318490D0 (en) * 2013-10-18 2013-12-04 Genovis Ab Method
CN106660967A (zh) 2014-01-24 2017-05-10 西纳福克斯股份有限公司 (杂)芳基1,3‑偶极化合物与(杂)环炔的环加成方法
EP3682904A1 (en) 2014-06-30 2020-07-22 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
GB201413240D0 (en) * 2014-07-25 2014-09-10 Hansa Medical Ab Method
EP3177633B1 (en) 2014-08-04 2022-07-20 SynAffix B.V. Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
HRP20180439T1 (hr) 2015-04-23 2018-07-13 Synaffix B.V. Postupak modificiranja glikoproteina glikoziltransferazom koja je ili je derivat beta-(1,4)-n-acetilgalaktozaminil transferaze
WO2017124084A1 (en) * 2016-01-15 2017-07-20 University Of Maryland, College Park Endo-s2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
AU2017214441B2 (en) * 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases
TWI706035B (zh) * 2016-08-24 2020-10-01 醣基生醫股份有限公司 利用醣苷內切酶突變體重塑醣蛋白及其使用方法
CN111183220B (zh) 2017-05-26 2024-03-22 杰诺维斯公司 用于聚糖分析的工具
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
US20210402002A1 (en) 2018-06-19 2021-12-30 Glykos Biomedical Oy Conjugate
CA3102155A1 (en) 2018-06-29 2020-01-02 Glykos Biomedical Oy Conjugates
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate
CN111044731B (zh) * 2019-12-19 2021-05-07 北京科技大学 脉冲温育免疫反应分离富集多肽药物中肽类杂质的方法
TW202140075A (zh) 2020-01-09 2021-11-01 美商梅爾莎納醫療公司 具有含肽之連接子的位置特異性抗體-藥物共軛體
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
US20230374083A1 (en) * 2020-09-21 2023-11-23 Shanghai Bao Pharmaceuticals Co., Ltd. Pharmaceutical combination and use thereof
CA3203721A1 (en) 2021-01-04 2022-07-07 Timothy B. Lowinger B7h4-targeted antibody-drug conjugates and methods of use thereof
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
CN115873833B (zh) * 2022-11-08 2024-08-16 上海泰昶生物技术有限公司 生产免疫球蛋白g降解酶的工程菌株和工艺
CN117165643B (zh) * 2023-08-17 2025-10-28 山东大学 一种糖苷内切酶在水解高甘露糖型n-糖蛋白中的应用
WO2025098484A1 (zh) * 2023-11-10 2025-05-15 上海齐鲁制药研究中心有限公司 新型Endo S2突变体酶
WO2025248500A1 (en) 2024-05-31 2025-12-04 Janssen Biotech, Inc. Antibody drug conjugates that target enpp3

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008071418A2 (en) * 2006-12-13 2008-06-19 Hansa Medical Ab Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
WO2009033670A2 (en) * 2007-09-14 2009-03-19 Genovis Ab Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
GB0821100D0 (en) 2008-11-18 2008-12-24 Hansa Medical Ab Antibodies
JP2013506404A (ja) * 2009-10-02 2013-02-28 ロシュ グリクアート アーゲー 抗体における非フコシル化の検出法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008071418A2 (en) * 2006-12-13 2008-06-19 Hansa Medical Ab Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
WO2009033670A2 (en) * 2007-09-14 2009-03-19 Genovis Ab Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
McShan, W. M. et al., J. Bacteriology, 2008, vol. 190, no. 23, pages 7773-7785 *

Also Published As

Publication number Publication date
BR112014005816A2 (pt) 2020-12-29
CA2848230A1 (en) 2013-03-21
WO2013037824A1 (en) 2013-03-21
ZA201401840B (en) 2018-05-30
PL2756077T3 (pl) 2017-09-29
GB201406321D0 (en) 2014-05-21
GB201115841D0 (en) 2011-10-26
EP2756077B1 (en) 2017-03-29
JP2014531205A (ja) 2014-11-27
KR102001427B1 (ko) 2019-07-18
PT2756077T (pt) 2017-06-21
MX2014002906A (es) 2014-10-17
EA201490447A1 (ru) 2014-09-30
MX347727B (es) 2017-05-10
KR20140081813A (ko) 2014-07-01
SG11201400505YA (en) 2014-04-28
EA028490B1 (ru) 2017-11-30
US9493752B2 (en) 2016-11-15
DK2756077T3 (en) 2017-07-03
CN103946377B (zh) 2016-10-05
JP6076349B2 (ja) 2017-02-08
ES2627334T3 (es) 2017-07-27
AU2012307461A1 (en) 2014-03-27
EA028490B8 (ru) 2018-01-31
NZ622172A (en) 2016-04-29
CN103946377A (zh) 2014-07-23
IL231410A0 (en) 2014-04-30
US20140302519A1 (en) 2014-10-09
EP2756077A1 (en) 2014-07-23
CA2848230C (en) 2020-03-24
IN2014CN02163A (enExample) 2015-05-29
GB2509284A (en) 2014-06-25

Similar Documents

Publication Publication Date Title
AU2012307461B2 (en) Endoglycosidase from Streptococcus pyogenes and methods using it
AU2015267051B2 (en) Fucosidase from bacteroides and methods using the same
US8323908B2 (en) Method of assessing glycosylation state or functional quality of an IgG containing sample
JP7557896B2 (ja) O-糖タンパク質のためのプロテアーゼ及び結合ポリペプチド
NZ622172B2 (en) Endoglycosidase from streptococcus pyogenes and methods using it

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)